Research progress of GPC3-targeted CAR-T immunotherapy in hepatocellular carcinoma
Hepatocellular carcinoma（HCC）is one of the most prevalent malignant tumors globally,characterized by its high degree of malignancy,challenging treatment options,and poor prognosis. Chimeric antigen receptor T cell（CAR-T）therapy,as an innovative therapeutic strategy,has advanced to the fifth generati...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Chinês |
| Pubblicazione: |
The Editorial Department of Chinese Journal of Clinical Research
2026-05-01
|
| Serie: | Zhongguo linchuang yanjiu |
| Soggetti: | |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|